National blood transfusion and component utilisation trends in Colombia, 2019–2024: A time‐series analysis

OBJECTIVE: To characterise national trends in blood transfusion activity, blood component utilisation, blood supply indicators and regional variability in Colombia between 2019 and 2024, encompassing the pre-pandemic, pandemic and recovery phases. BACKGROUND: Monitoring national transfusion activity provides insight into healthcare system performance and blood-supply management. While several high-income countries have reported stable or declining transfusion rates, longitudinal national data from middle-income settings remain limited. METHODS/MATERIALS: A retrospective time-series study was conducted using national blood transfusion surveillance data from Colombia (2019-2024). Annual reports from the Colombian National Institute of Health were analysed to evaluate blood donation activity, blood component utilisation, transfusion practices and regional transfusion rates. RESULTS: A total of 8 438 003 blood components were transfused across 653 healthcare institutions. National red blood cell (RBC) collection rates increased from 27.2 units per 1000 population in 2019 to 27.9 in 2024. RBC transfusion rates decreased from 18.6 per 1000 inhabitants in 2019 to 15.8 in 2020 and partially recovered to 16.8 in 2024. Buffy coat-derived platelet utilisation decreased from 14.6% to 10.0%, whereas apheresis platelet and cryoprecipitate utilisation increased from 7.8% to 9.2% and from 5.0% to 6.8%, respectively. Adult intensive care units remained the largest consumers of blood products, accounting for 27%-30% of all transfusions. Regional variability in transfusion rates persisted despite post-pandemic recovery. CONCLUSION: The Colombian blood network demonstrated resilience following the COVID-19 pandemic. By 2024, blood collection and utilisation had stabilised at levels approaching those observed before the pandemic, suggesting the establishment of a new equilibrium in blood supply and demand.

Authors

Institutions

Publication Details

Journal
Transfusion Medicine
Published
2026-11-18
DOI
https://doi.org/10.1111/tme.70136
Primary Topic
Blood donation and transfusion practices
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

National blood transfusion and component utilisation trends in Colombia, 2019–2024: A time‐series analysis

Michel‐Andrés García‐Otálora, Javier Rojas-Marulanda, Santiago Bolívar‐Areiza, Lauren Torres‐Pineda et al.
1 links
Transfusion Medicine
Blood donation and transfusion practices
article

National blood transfusion and component utilisation trends in Colombia, 2019–2024: A time‐series analysis

Michel‐Andrés García‐Otálora, Javier Rojas-Marulanda, Santiago Bolívar‐Areiza, Lauren Torres‐Pineda, María‐Paula Patiño‐Rattiva, Sara Rodríguez‐González
article en

Abstract

OBJECTIVE: To characterise national trends in blood transfusion activity, blood component utilisation, blood supply indicators and regional variability in Colombia between 2019 and 2024, encompassing the pre-pandemic, pandemic and recovery phases. BACKGROUND: Monitoring national transfusion activity provides insight into healthcare system performance and blood-supply management. While several high-income countries have reported stable or declining transfusion rates, longitudinal national data from middle-income settings remain limited. METHODS/MATERIALS: A retrospective time-series study was conducted using national blood transfusion surveillance data from Colombia (2019-2024). Annual reports from the Colombian National Institute of Health were analysed to evaluate blood donation activity, blood component utilisation, transfusion practices and regional transfusion rates. RESULTS: A total of 8 438 003 blood components were transfused across 653 healthcare institutions. National red blood cell (RBC) collection rates increased from 27.2 units per 1000 population in 2019 to 27.9 in 2024. RBC transfusion rates decreased from 18.6 per 1000 inhabitants in 2019 to 15.8 in 2020 and partially recovered to 16.8 in 2024. Buffy coat-derived platelet utilisation decreased from 14.6% to 10.0%, whereas apheresis platelet and cryoprecipitate utilisation increased from 7.8% to 9.2% and from 5.0% to 6.8%, respectively. Adult intensive care units remained the largest consumers of blood products, accounting for 27%-30% of all transfusions. Regional variability in transfusion rates persisted despite post-pandemic recovery. CONCLUSION: The Colombian blood network demonstrated resilience following the COVID-19 pandemic. By 2024, blood collection and utilisation had stabilised at levels approaching those observed before the pandemic, suggesting the establishment of a new equilibrium in blood supply and demand.

Transfusion Medicine
Universidad del Rosario (CO)
Good health and well-being
Blood donation and transfusion practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon